Zobrazeno 1 - 10
of 15
pro vyhledávání: '"L. M. Kudelya"'
Publikováno v:
Медицинская иммунология, Vol 22, Iss 6, Pp 1215-1220 (2021)
Hereditary angioedema (HAE) is a rare autosomal dominant disease caused by quantitative (type I) or functional (type II) deficiency in C1 esterase inhibitor (C1-INH). It may be caused by new mutations in up to 20% of patients. Prevalence of HAE is un
Externí odkaz:
https://doaj.org/article/a617cd7e7034474885922215c2a67835
Autor:
L. I. Alekseeva, S. A. Terpigorev, E. V. Zonova, L. M. Kudelya, N. M. Babadaeva, A. V. Teteneva, A. A. Kondrashov, D. N. Orlov, T. V. Raskina, O. N. Anoshenkova, Yu. P. Chasovskikh, T. V. Kropotina, A. B. Opongosheva, N. V. Yudina, N. G. Ganyukova
Publikováno v:
Бюллетень сибирской медицины, Vol 19, Iss 3, Pp 113-119 (2020)
The aim of the study was to develop ways to improve the diagnosis and treatment of systemic sclerosis (SSc)-ILD. Interstitial lung disease (ILD) is a common manifestation of SSc. In the territory of the Siberian Federal District (SFD), the number of
Externí odkaz:
https://doaj.org/article/ed3f55c0201841c4a4916cb184a1c1c4
Autor:
L. M. Kudelya, Ya. L. Manakova, E. S. Khusainova, E. A. Drobyazgin, A. V. Kutepov, A. M. Gorbovskaya, A. V. Korobeynikov, L. A. Bogoderova, I. A. Zubritskaya, V. F. Khusainov, K. I. Shcherbina
Publikováno v:
Сибирский научный медицинский журнал, Vol 40, Iss 1, Pp 138-143 (2020)
The aim of the research is to study nosological structure, features of kidney, lung damage, deaths in patients with ANCA – associated vasculitis underwent medical treatment in a multidisciplinary hospital. Material and methods. Selection and subseq
Externí odkaz:
https://doaj.org/article/86f223cbb805428881f2d3529c7b32ce
Autor:
S. N. Avdeev, O. A. Volkova, I. V. Demko, G. L. Ignatova, I. V. Leshchenko, N. A. Kanukova, L. M. Kudelya, V. A. Nevzorova, N. G. Nedashkovskaya, O. P. Ukhanova, L. V. Shulzhenko, R. S. Fassakhov
Publikováno v:
Терапевтический архив, Vol 92, Iss 2, Pp 119-123 (2020)
The meeting of the Expert board was held in Moscow on June 24, 2019, at which the following issues were considered: the applicability of a new terminology characterizing asthma endotypes and phenotypes in real clinical practice, the effect of phenoty
Externí odkaz:
https://doaj.org/article/082d95f3de224abc9351d6044e1c870d
Publikováno v:
Acta Biomedica Scientifica, Vol 0, Iss 1, Pp 56-59 (2012)
One of the important problems with patients with Hodgkin's lymphoma is lung injury, caused both by a tumor effect and the influence of chemoradiotherapy. Before the treatment an obstructive lung function pattern connected with tumor substrate has bee
Externí odkaz:
https://doaj.org/article/57929760961e45978f820113222ac9cf
Autor:
S. N. Avdeev, Z. R. Aisanov, V. V. Arkhipov, A. S. Belevskiy, A. A. Vizel, I. V. Demko, A. V. Emelyanov, A. A. Zaycev, G. L. Ignatova, N. P. Kniajeskaia, L. M. Kudelya, I. V. Leshchenko, S. I. Ovcharenko, A. I. Sinopalnikov, I. N. Trofimenko, V. D. Fedotov, R. F. Khamitov
Publikováno v:
PULMONOLOGIYA. 33:109-118
Chronic obstructive pulmonary disease (COPD) is a progressing disease. Each exacerbation impairs the patient’s prognosis and increases burden for the healthcare system. The most common maintenance treatment options for COPD include long-acting bron
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d5704e94708cbb7c319d471536942f02
https://doi.org/10.18093/0869-0189-202333-1-109-118
https://doi.org/10.18093/0869-0189-202333-1-109-118
Comparative Study cf Biosimilar Genolar® Clinical Efficacy оп the Randomized Phase III Study Results
Autor:
D. V. Petrov, G. L. Osipova, V. N. Zorin, N. E. Kostina, N. A. Kuzubova, T. V. Rubanik, N. I. Il'ina, A. V. Averyanov, L. M. Kudelya, A. O. Molotkov, Sergey Avdeev, N. M. Nenasheva
Publikováno v:
PULMONOLOGIYA. 30:782-796
There are results of a comparative phase III clinical study on the efficiency and safety of the biosimilar drug Genolar® (Generium JSC, Russia) and the reference drug Xolair® (Novartis Pharma AG, Switzerland) ((NCT04607629). The study is aimed to e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::93a8819f65740ba9eea27156213c53da
https://doi.org/10.18093/0869-0189-2020-30-6-782-796
https://doi.org/10.18093/0869-0189-2020-30-6-782-796
Autor:
Ch. Ch. Mandarzhap, L. M. Kudelya, Elena Sobko, I. A. Soloveva, Irina Demko, N. S. Gyrgeshkinova, N. G. Ganyukova, A. V. Tetenevа, I. N. Trofimenko, A. A. Grebenyuk, S. A. Luk'yanov, O. A. Meshcheryakova
Publikováno v:
Russian Pulmonology. 30:245-251
Chronic obstructive pulmonary disease (COPD) is a global problem in modern medicine. In recent years, the medical community’s understanding of COPD has changed significantly, which is primarily due to the emergence of a new classification and the i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::12a6b377f3b765e897b72b75e01a7300
https://doi.org/10.18093/0869-0189-2020-30-2-245-251
https://doi.org/10.18093/0869-0189-2020-30-2-245-251
Autor:
O. P. Uhanova, L. S. Kozyreva, S. V. Trishina, T. A. Stepanenko, S. Krasovskiy, N. Ponomareva, G. N. Seitova, L. M. Kudelya, E. L. Amelina, D. I. Abdulganieva, N. P. Revel-Muroz, O. V. Magnitskaya, I. E. Zilber, I. K. Asherova, T. G. Fadeeva, E. M. Reutskaya
Publikováno v:
Russian Pulmonology. 29:695-706
The article discusses the results of a phase III clinical trial to compare the pharmacokinetics, efficacy and safety of the biosimilar medicinal product Tigerase® (dornase alpha) (Generium JSC, Russia) and the reference medicinal product Pulmozyme®
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3a4fd35ddde83031463bab48d0e702ea
https://doi.org/10.18093/0869-0189-2019-29-6-695-706
https://doi.org/10.18093/0869-0189-2019-29-6-695-706
Autor:
L V Shulzhenko, Vera Nevzorova, N G Nedashkovskaya, L M Kudelya, Sergey Avdeev, I V Leshchenko, O P Ukhanova, O A Volkova, I. V. Demko, R S Fassakhov, G L Ignatova, N A Kanukova
Publikováno v:
Терапевтический архив, Vol 92, Iss 2, Pp 119-123 (2020)
The meeting of the Expert board was held in Moscow on June 24, 2019, at which the following issues were considered: the applicability of a new terminology characterizing asthma endotypes and phenotypes in real clinical practice, the effect of phenoty
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5fe77fbe11dfe8e3730c5cb8e584c534
https://ter-arkhiv.ru/0040-3660/article/viewFile/33924/pdf
https://ter-arkhiv.ru/0040-3660/article/viewFile/33924/pdf